Platzer Erich's Form 4 filing
Aptose Biosciences Inc. (APTO) · filed Dec 20, 2021
- Accession no.
- 0001567619-21-022331
- Filed
- Dec 20, 2021
- Trade date
- Dec 16, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $137.9K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Platzer ErichCIK 0001275087 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | Common Shares | PPurchaseAcquired | +50,000 | $1.37 | +$68,500 | 455,000 | Direct | |
| Dec 16, 2021 | Common Shares | PPurchaseAcquired | +30,000 | $1.38 | +$41,400 | 485,000 | Direct | |
| Dec 16, 2021 | Common Shares | PPurchaseAcquired | +20,000 | $1.40 | +$28,000 | 505,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.